FridayNov 04, 2022 11:26 am

Experts Concerned That Concussion Protocols Don’t Factor in Women

Since the early 2000s, research on concussions has improved significantly. Concussions are traumatic brain injuries that affect the brain function of an individual. It is estimated that millions of Americans experience concussions annually, with a survey conducted by the CDC in 2017 finding that 2.5 million students in high school had experienced concussions in 2016. Of this figure, which represents about 15% of all students in high school in the country, at least 40% of those who experienced concussions were girls. While increasing awareness among the American public may have led to the greater numbers of teens reporting concussions, not…

Continue Reading

FridayNov 04, 2022 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Extends Columbia University Agreement to Continue Research for Therapeutics to Treat Alzheimer’s Disease

Silo recently extended Columbia University agreement to continue research for novel therapeutics to treat Alzheimer’s disease and stress-induced anxiety disorder Preclinical studies demonstrate Silo’s jointly-developed Z-pod(TM) delivery technology holds and distributes therapeutics in a time-released manner to potentially provide targeted delivery Additional treatment research includes funding for the UCSF Translational Psychedelic Program to study effects of psilocybin on various inflammatory conditions Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company, fuses traditional therapeutics with psychedelic medicine to treat numerous underserved conditions, including fibromyalgia, post-traumatic stress disorder, and Alzheimer’s disease. Through a joint partnership agreement with Columbia University, researchers are currently…

Continue Reading

ThursdayNov 03, 2022 1:43 pm

Research Finds That Stem Cells Reduce Lung Transplant Rejection Rates

Organ rejection usually occurs when the immune system of the recipient of a transplanted organ treats the transplanted organ as a foreign object and attacks it. At the moment, patients can only reduce the risk of organ rejection by taking immunosuppressants, which alleviate symptoms of rejection but make patients more susceptible to infections. It is estimated that over one-half of patients who receive donor lungs experience organ rejection. Researchers believe that frequent rejection rates and continuous exposure to bacteria and particulates in the air cause irritation while also stimulating the immune system to attack the donor lungs. While medical advancements…

Continue Reading

WednesdayNov 02, 2022 1:01 pm

Study Finds Covid-19 Spikes Linked to Increases in Heart Attacks

More than two years after the novel coronavirus was first discovered in Wuhan, China, the infectious virus is still wreaking havoc among the global population. Although most countries, with the notable exception of China, have almost wholly loosened their tight pandemic policies, the respiratory disease is still taking lives every day. By mid-September 2022, hundreds of Americans were still losing their lives to COVID, with Centers for Disease Control and Prevention’s director, Dr. Rochelle Walensky, stating that the country was losing up to 375 patients per day due to the virus. Data from the Cedars Sinai Smidt Heart Institute has…

Continue Reading

WednesdayNov 02, 2022 9:45 am

India Globalization Capital Inc. (NYSE American: IGC) Is ‘One to Watch’

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC based formulation on Alzheimer’s patients The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. India Globalization Capital (NYSE American: IGC), through subsidiary…

Continue Reading

TuesdayNov 01, 2022 11:29 am

Study Finds Epigenetics May Revolutionize Treatment of Cancer

A new study has led to the discovery of new information about the role of epigenetics in cancer development. Epigenetics refers to the study of how an individual’s environment and behaviors cause changes that affect the way their genes work. The study, which was conducted by scientists at the Institute of Cancer Research in London, suggests that dark matter may change the detection and treatment of cancer. It may also facilitate the development of new tests for this illness, which will be useful in tailoring therapies. Prior studies have primarily focused on how structural changes to individual DNA, which cause…

Continue Reading

MondayOct 31, 2022 11:16 am

New Research Uncovers Racial Disparities in Treatment of Heart Failure

New research has discovered racial disparities in the provision of treatment for advanced heart failure. The research, which was supported by the National Institutes of Health, found that Black individuals received life-changing treatments almost one-half as often as their White counterparts. Previous research has demonstrated that Black individuals are two times more likely to succumb to heart failure. This is in addition to having a higher risk for experiencing heart failure. For their research, investigators followed 377 patients who received the treatment at a selected center out of the 21 centers in America. White adults made up 277 of the…

Continue Reading

FridayOct 28, 2022 9:44 am

Why Food Allergies May Be Increasing

Food allergies have become more common these past few years in both adults as well as children. Allergies are defined as the immune system’s overreaction to an antibody known as immunoglobulin E. This protein is usually produced by the immune system to help detect and attack invaders. When the body identifies a threat, it triggers histamine production, which in turn prompts an allergic reaction in an effort to eliminate the threat. You may notice that when an individual is reacting to something, their skin may itch and their tissues inflame; they may also wheeze, sneeze or cough. Data from the…

Continue Reading

ThursdayOct 27, 2022 10:27 am

Researchers Discover New Way to Noninvasively Monitor Immune Cells Inside Tumors

Scientists have designed a new strategy to noninvasively track macrophages in tumors in the breast and brain. Macrophages are immune cells that play a crucial role in the immune system, carrying out a number of functions, including clearing out dead cells and digesting microorganisms. These cells are often recruited by cancer to increase resistance to treatment and support tumor growth. The Ludwig Cancer Research study, led by Davide Croci and Johanna Joyce, also involved their colleague Ruud B. van Heeswijk from the Lausanne University Hospital. Joyce stated that monitoring tumor-associated macrophages had the potential to substantially improve how various cancers…

Continue Reading

WednesdayOct 26, 2022 2:48 pm

Study Finds Smart Watches Can Accurately Detect Atrial Fibrillation

New research has found that smart watches can be used to detect atrial fibrillation accurately using an electrocardiogram application. Atrial fibrillation is an irregular heart rhythm that may cause blood clots. It also heightens an individual’s risk of heart failure and stroke, among other heart-related complications. The research, which was conducted earlier this year, discovered that the Apple Watch could be used to diagnose this arrhythmia. For their study, the researchers looked into the accuracy of this device when testing individuals who had abnormal electrocardiograms. The lead author of the study, Dr. Marc Strick, stated that this technology was widely…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050